These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9788127)

  • 21. Statins, cholesterol, and mevalonate pathways?
    Lewis LS
    Lancet; 1996 Feb; 347(9000):551. PubMed ID: 8596303
    [No Abstract]   [Full Text] [Related]  

  • 22. Crossover trial of simvastatin versus pravastatin in patients with primary hypercholesterolemia.
    Sasaki S; Sawada S; Nakata T; Itoh H; Takeda K; Nakagawa M; Kuriyama K
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):142-7. PubMed ID: 9268234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.
    Aronow WS; Ahn C
    Am J Cardiol; 2002 Oct; 90(7):789-91. PubMed ID: 12356403
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins and coronary artery disease--it's the clinical endpoints that count.
    Jackson G
    Br J Clin Pract; 1997; 51(1):2-3. PubMed ID: 9158261
    [No Abstract]   [Full Text] [Related]  

  • 25. Do statin drugs lower the risk of stroke?
    Sabharwal M; Por CP; Evans MF
    Can Fam Physician; 1998 May; 44():1003-4. PubMed ID: 9612584
    [No Abstract]   [Full Text] [Related]  

  • 26. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients.
    Contermans J; Smit JW; Bär PR; Erkelens DW
    Br J Clin Pharmacol; 1995 Feb; 39(2):135-41. PubMed ID: 7742151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins and dementia.
    Golomb BA; Jaworski B
    Arch Neurol; 2001 Jul; 58(7):1169-70. PubMed ID: 11448316
    [No Abstract]   [Full Text] [Related]  

  • 29. Pravastatin versus simvastatin--what happens in the real world?
    Levenstein S
    S Afr Med J; 1995 May; 85(5):388-91. PubMed ID: 7638696
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of new drugs for lowering plasma cholesterol concentrations.
    Illingworth DR
    Drugs; 1991 Feb; 41(2):151-60. PubMed ID: 1709846
    [No Abstract]   [Full Text] [Related]  

  • 32. Improved survival with statin therapy.
    Clem JR
    S D J Med; 1996 Aug; 49(8):273-4. PubMed ID: 8803474
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin. The Quality of Life Multicenter Group.
    Weir MR; Berger ML; Weeks ML; Liss CL; Santanello NC
    Am J Cardiol; 1996 Mar; 77(7):475-9. PubMed ID: 8629587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins and coronary heart disease.
    Oliver MF
    Lancet; 1996 Jul; 348(9019):57. PubMed ID: 8691943
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group.
    Lambrecht LJ; Malini PL
    Acta Cardiol; 1993; 48(6):541-54. PubMed ID: 8122478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ; Keller U; Oberhänsli A; Riesen WF
    Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Worldwide experience with simvastatin/lovastatin.
    Walker JF
    Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.